Cello Group buys Advantage Healthcare

The deal involves an initial $1.5m will be paid in cash, with up to $3.0m in cash and shares deferred, dependent on its 2017 to 2021 financial performance

Advantage Healthcare was founded by Debbie Glick more than 20 years ago and gives critical analysis and insights in biopharmaceuticals, supporting new products and business development.

Based in Princeton, New Jersey, US, it achieved a turnover of $4.5m and gross profit of $3m for the year to 31 December 2016.

Advantage Healthcare adds to Cello Health’s work for clients from the early stages of drug development onward. It is also consistent with reinforcing Cello Health’s commitment to the core US market and its overall aim of becoming a leading global health services company.

Debbie Glick, founder of Advantage Healthcare, said: "Joining Cello Health will provide a win-win combination for our global healthcare clients, offering a broad base of strategic expertise and service in the pipeline and marketed products across nearly 100 disease categories."